Monopar Therapeutics Inc.Monopar Therapeutics Inc.Monopar Therapeutics Inc.

Monopar Therapeutics Inc.

No trades
See on Supercharts

Price target

43.250.000.00%
The 4 analysts offering 1 year price forecasts for MNPR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to MNPR in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MNPR EPS for the last quarter is −0.37 USD despite the estimation of −1.00 USD. In the next quarter EPS is expected to reach −0.38 USD. Track more of Monopar Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Monopar Therapeutics Inc. revenue is expected to reach 0.00 USD. Check out Monopar Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, MNPR price target is 43.25 USD with a max estimate of 91.00 USD and a min estimate of 22.00 USD. Check if this forecast comes true in a year, meanwhile watch Monopar Therapeutics Inc. stock price chart and keep track of the current situation with MNPR news and stock market news.